We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
Article purchase
Temporarily unavailable
References
1
Patel, M.Mitochondrial dysfunction and oxidative stress: cause and consequence of epileptic seizures. Free Radic Biol Med. 2004;37(12):1951–1962.Google Scholar
2
Wallace, DC.A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet. 2005;39:359–407.Google Scholar
3
Andreazza, AC, Kauer-Sant’Anna, M, Frey, BN, et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disorders. 2008;111(2-3):135–144.Google Scholar
4
Patel, M.A metabolic paradigm for epilepsy. Epilepsy Curr. 2018;18(5):318–322.Google Scholar
5
Ji, D, Mylvaganam, S, Ravi Chander, P, Tarnopolsky, M, Murphy, K, Carlen, P.Mitochondria and oxidative stress in epilepsy: advances in antioxidant therapy. Front Pharmacol. 2025;15:1505867. https://doi.org/10.3389/fphar.2024.1505867.Google Scholar
6
Zachos, KA, Gamboa, JA, Dewji, AS, Lee, J, Brijbassi, S, Andreazza, AC.The interplay between mitochondria, the gut microbiome and metabolites and their therapeutic potential in primary mitochondrial disease. Front Pharmacol. 2024;15:1428242.Google Scholar
7
Abdelmalik, PA, Politzer, N, Carlen, PL.Magnesium as an effective adjunct therapy for drug resistant seizures. Can J Neurol Sci. 2012;39(3):323–327.Google Scholar